Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study.
Aihara T, Takatsuka Y, Ohsumi S, Aogi K, Hozumi Y, Imoto S, Mukai H, Iwata H, Watanabe T, Shimizu C, Nakagami K, Tamura M, Ito T, Masuda N, Ogino N, Hisamatsu K, Mitsuyama S, Abe H, Tanaka S, Yamaguchi T, Ohashi Y. Aihara T, et al. Among authors: ogino n. Breast Cancer Res Treat. 2010 Jun;121(2):379-87. doi: 10.1007/s10549-010-0888-x. Breast Cancer Res Treat. 2010. PMID: 20390343 Clinical Trial.
Study of low-dose capecitabine monotherapy for metastatic breast cancer.
Taguchi T, Nakayama T, Masuda N, Yoshidome K, Akagi K, Nishida Y, Yoshikawa Y, Ogino N, Abe C, Sakamoto J, Noguchi S; Kinki Breast Cancer Study Group. Taguchi T, et al. Among authors: ogino n. Chemotherapy. 2010;56(2):166-70. doi: 10.1159/000313531. Epub 2010 Apr 21. Chemotherapy. 2010. PMID: 20407245 Clinical Trial.
Independent prognostic factors in breast cancer patients.
Narita M, Nakao K, Ogino N, Nakahara M, Onishi A, Tsujimoto M. Narita M, et al. Among authors: ogino n. Am J Surg. 1998 Jan;175(1):73-5. doi: 10.1016/s0002-9610(97)00225-0. Am J Surg. 1998. PMID: 9445246
[Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
Nishi T, Yamanaka E, Yamasaki M, Tanaka H, Takeda C, Ikeda N, Hoashi T, Higaki J, Matsunami T, Nakano K, Kogire M, Furukawa J, Inui N, Yamauchi E, Takagaki K, Ogino N, Nomura T, Yamada S, Fujimoto M, Uenishi M, Yayoi E; Osaka Breast Cancer Treatment Group. Nishi T, et al. Among authors: ogino n. Gan To Kagaku Ryoho. 2004 Jun;31(6):897-901. Gan To Kagaku Ryoho. 2004. PMID: 15222108 Clinical Trial. Japanese.
260 results